Skip to main content
Clinical Trials/JPRN-UMIN000005497
JPRN-UMIN000005497
Recruiting
未知

Tissue Doppler Imaging: New Ultrasonographic Method for Evaluating Wall Motion of Cervical Esophagus during Swallowing - Evaluation of swallow function with US technology using TDI

Kawasaki Medical School0 sites100 target enrollmentApril 24, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
patients with globus sensation and/or dysphagia
Sponsor
Kawasaki Medical School
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 24, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • All patients underwent both the larygoscopy and the upper gastrointestinal endoscopy to exclude organic diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Feasibility of the use of Ultrasound Doppler-derived patient-specific velocity profiles in fluid-structure interaction modelling of the abdominal aorta, femoral artery and carotid artery'Aneurysm''Dilated artery''Narrowed artery''Stenosis'10002363
NL-OMON53799Catharina-ziekenhuis48
Recruiting
Not Applicable
Clinical applications of non invasive Doppler ultrasound urodynamic studyBenign prostatic hypertrophy Neurogenic bladder
JPRN-UMIN000011309Kawasaki Medical School General Medical Center300
Completed
Phase 2
A new technique of transverse ultrasound imaging for identification of lumbar intervertebral level compare to palpation techniquediagnosis toolspalpation method&#44transverse scan&#44ultrasound&#44lumbar identification
TCTR20181008001Faculty of Medicine, Prince of Songkla University28
Active, not recruiting
Phase 1
Doppler sonography (non-invasive test that calculates blood flow in blood vessels) of skin and nodal metastases (cancer spread from the skin, where it was originally formed, to the nodal tissue) as a predictor of clinical response to Talimogene Laherparepvec (T-VEC), biopharmaceutical drug to treat melanoma lesions that can not be operated, in melanoma patients (T-VEC – US Doppler)Melanoma stage IIIB-IVM1aTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2018-002677-22-ESFundació Clínic per a la Recerca Biomèdica25
Active, not recruiting
Phase 1
Doppler ultrasound investigation of microvasculature in health and diseaseDiabetes mellitus Hypertension
EUCTR2006-005406-32-GBBelfast City Hospital Trust120